Latest & greatest articles for influenza

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on influenza or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on influenza and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for influenza

1. Avian influenza: PGD templates

National lockdown: stay at home Check what you need to do Guidance Avian influenza: PGD templates Patient group direction (PGD) templates for the supply of oseltamivir for pre and post exposure prophylaxis of avian influenza (flu). Published 12 January 2016 Last updated 22 January 2021 — From: Documents Ref: PHE publications gateway number 2015363 MS Word Document , 300KB This file may not be suitable for users of assistive technology. Request an accessible format. If you use assistive technology (...) exposure prophylaxis of non H7N9 and H5N8 avian influenza: . Published 12 January 2016 Last updated 22 January 2021 22 January 2021 Updated 2 patient group direction (PGD) templates. 17 April 2019 Added new oseltamivir guidance for H7N9 avian flu. 13 February 2018 Updated template documents. 20 March 2017 Added PGD template for post exposure prophylaxis for Avian Influenza A (H5N8). 6 March 2017 Link for Template patient group directions for Avian Influenza incidents has been added. 12 January 2016

2021 Public Health England

2. Baloxavir marboxil (Xofluza) - antiviral medicine for treating and preventing influenza

, baloxavir marboxil, blocks an enzyme known as CEN, which the influenza virus uses to produce more copies of itself. By interfering with the activity of this enzyme, the medicine can treat the infection and prevent infection in patients exposed to the virus. What benefits of Xofluza have been shown in studies? Treating flu A main study in 1,436 otherwise healthy patients with uncomplicated flu showed that Xofluza was effective in speeding up recovery from flu symptoms. Patients who took Xofluza recovered (...) Baloxavir marboxil (Xofluza) - antiviral medicine for treating and preventing influenza Official address Domenico Scarlattilaan 6 ? 1083 HS Amsterdam ? The Netherlands An agency of the European Union Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 © European Medicines Agency, 2021. Reproduction is authorised provided the source is acknowledged. EMA/648596/2020 EMEA/H/C/004974 Xofluza

2021 European Medicines Agency - EPARs

3. Safety of influenza vaccine for women and their newborns if received during pregnancy

Safety of influenza vaccine for women and their newborns if received during pregnancy DSEN Abstract: Safety and effectiveness of influenza vaccine during pregnancy - CIHR Language selection Search and menus Search Search website Search Topics menu You are here: DSEN Abstract Safety and effectiveness of influenza vaccine during pregnancy *This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the following investigators: Anick Bérard, Vanina Tchuente, Sasha (...) Bernatsky, William Fraser, Caroline Quach. The statements made herein are those of the stated authors, who are independent researchers. What is the current situation? National Advisory Committee on Immunization has recommended the influenza vaccine for all pregnant women since 2007, as a strategy to reduce the risk of influenza infection in infants less than 6 months of age (who are unable themselves to be vaccinated). Despite recommendations, influenza vaccination uptake during pregnancy remains low

2021 Drug Safety and Effectiveness Network

4. Inactivated influenza vaccine: information for healthcare practitioners

for the flu season 2019 to 2020. 27 September 2018 Added new revised version of document. 8 August 2018 Added national influenza programme guidance for the inactivated influenza vaccine. 15 August 2017 Added link to slideset for the 2017 to 2018 national flu immunisation programme; for viewing and downloading. 7 August 2017 Revised guidance for the 2017 to 2018 flu season. 10 November 2016 Updated to include questions on air bubbles in pre-filled syringes and giving flu vaccine to patients taking oral (...) Inactivated influenza vaccine: information for healthcare practitioners Inactivated influenza vaccine: information for healthcare practitioners - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Inactivated

2020 Public Health England

5. Influenza quadrivalent vaccine (Supemtek)

Influenza quadrivalent vaccine (Supemtek) Official address Domenico Scarlattilaan 6 ? 1083 HS Amsterdam ? The Netherlands An agency of the European Union Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 © European Medicines Agency, 2020. Reproduction is authorised provided the source is acknowledged. 17 September 2020 EMA/522939/2020 Committee for Medicinal Products for Human Use (CHMP (...) ) Assessment report Supemtek Common name: influenza quadrivalent vaccine (rDNA) Procedure No. EMEA/H/C/005159/0000 Note Assessment report as adopted by the CHMP with all information of a commercially confidential nature deleted. Assessment report EMA/522939/2020 Page 2/99 Table of contents 1. Background information on the procedure 7 1.1. Submission of the dossier 7 1.2. Steps taken for the assessment of the product 8 2. Scientific discussion 9 2.1. Problem statement 9 2.1.1. Disease 9 2.1.2. Epidemiology

2020 European Medicines Agency - EPARs

6. Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study Full Text available with Trip Pro

Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from (...) the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} Live attenuated influenza vaccine was safe and decreased confirmed influenza in children, whereas this effect was smaller and less certain with the trivalent vaccine, particularly in over 65s. {{author}} {{($index , , , , , , , , , , , & . Colin R Simpson 1, 2, * , Nazir I Lone 2 , Kim Kavanagh 3 , Tanya Englishby 3 , Chris

2020 NIHR HTA programme

7. Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults

Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging (...) ahead of print. Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults , , , , , , , , , Affiliations Expand Affiliations 1 Janssen Vaccines & Prevention, Leiden, the Netherlands. 2 Janssen Infectious Diseases, Beerse, Belgium. 3 Coastal Carolina Research Center, Mount Pleasant, South Carolina. PMID: 32851411 DOI: Item in Clipboard Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered

2020 EvidenceUpdates

8. Elderberry Extract Outpatient Influenza Treatment for Emergency Room Patients Ages 5 and Above: a Randomized, Double-Blind, Placebo-Controlled Trial

Elderberry Extract Outpatient Influenza Treatment for Emergency Room Patients Ages 5 and Above: a Randomized, Double-Blind, Placebo-Controlled Trial Elderberry Extract Outpatient Influenza Treatment for Emergency Room Patients Ages 5 and Above: a Randomized, Double-Blind, Placebo-Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily (...) -3277. doi: 10.1007/s11606-020-06170-w. Epub 2020 Sep 14. Elderberry Extract Outpatient Influenza Treatment for Emergency Room Patients Ages 5 and Above: a Randomized, Double-Blind, Placebo-Controlled Trial , , , Affiliations Expand Affiliations 1 Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, USA. macknim@ccf.org. 2 , Beachwood, USA. macknim@ccf.org. 3 C5 Research, Cleveland Clinic, Cleveland, OH, USA. 4 Clinical Research Unit, Cleveland Clinic, Cleveland

2020 EvidenceUpdates

9. Operational considerations for influenza surveillance in the WHO European Region during COVID-19: interim guidance

meeting the ILI or ARI case definition should ideally be tested concurrently for influenza and SARS-CoV-2 viruses. • Epidemiological data on ILI should continue to be collected. • Perform subtyping/lineage determination for all influenza-positive specimens. • Where sentinel primary care surveillance for influenza has been disrupted because of COVID-19 testing strategies, explore alternative approaches such as patient self- sampling and the utility of telephone consultation syndromic data. For non (...) Influenza Centers (NICs) and the Global Influenza Surveillance and Response System (GISRS) [8]. In 2020, the WHO European Region has experienced widespread community transmission of COVID-19. In response, countries have implemented extensive public health and societal measures to slow its transmission. A range of surveillance systems are in place to monitor the progression and evolution of COVID-19 throughout the course of the pandemic [9]. These include a mix of syndromic and laboratory-based data

2020 European Centre for Disease Prevention and Control - Technical Guidance

10. Influenza: the green book, chapter 19

. Published 20 March 2013 Last updated 29 October 2020 29 October 2020 Updated to include information on the recombinant quadrivalent influenza vaccine. 23 April 2019 Updated the asthma and egg allergy sections and added information on newly licensed influenza vaccines. 15 August 2018 Updated section on administration of flu vaccine and general editing. 1 December 2017 Updated information on influenza vaccination in the elderly relating to the adjuvanted influenza vaccine. 18 October 2017 Updated (...) information on influenza vaccination relating to the benefit of quadrivalent vaccines. 28 August 2015 Clarification regarding asthma and egg allergy; updated background on the decision to extend vaccination to children, the choice of the LAIV vaccine and the benefit of quadrivalent vaccines. 26 August 2015 Extension of the influenza programme to children section has been deleted. 21 May 2015 The flu chapter of the Green Book has been updated to reflect the latest guidance from the Joint Committee

2020 Public Health England

11. COVID-19 and influenza point of care testing results: how to report

COVID-19 and influenza point of care testing results: how to report COVID-19 and influenza point of care testing results: how to report - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Show or hide search Search on GOV.UK Search Menu National restrictions in England from 5 November Take action (...) now for new rules in 2021 Guidance COVID-19 and influenza point of care testing results: how to report Notifications of COVID-19 and influenza point of care testing (POCT) results: legal duties for providers of POCT. Published 26 October 2020 From: Applies to: England Contents Print this page The regulations state that all COVID-19 and influenza positive, indeterminate, negative and void results from point of care testing ( . The 2010 Regulations are also being amended to require that, in addition

2020 Public Health England

12. Assessment of the Immune Effect and Safety of Cell Culture-Derived Influenza Vaccine from Egg-Derived by Meta Analysis Full Text available with Trip Pro

Assessment of the Immune Effect and Safety of Cell Culture-Derived Influenza Vaccine from Egg-Derived by Meta Analysis Assessment of the Immune Effect and Safety of Cell Culture-Derived Influenza Vaccine from Egg-Derived by Meta Analysis | International Journal of Innovative Research in Medical Science International Journal of Innovative Research in Medical Science Open Access Publication ISSN: 2455-8737 | Search Article Letter to the Editor Total : PDF: 45 | Total views: 45 Letter (...) to the Editor | Open Access Vol. 5 No. 10 (2020) | Page No.: 456 - 459 | Assessment of the Immune Effect and Safety of Cell Culture-Derived Influenza Vaccine from Egg-Derived by Meta Analysis Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College; Kunming, Yunnan Province, China; Zip Code: 650118 Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College; Kunming, Yunnan Province, China; Zip Code: 650118 Institute of Medical

2020 International Journal of Innovative Research in Medical Science

13. Flu immunisation for early years settings including child minders

in the General Election on 12 December. Guidance Flu immunisation for early years settings including child minders Guidance for early years childcare settings on the nasal spray flu (influenza) vaccination for preschool children. Published 16 September 2016 Last updated 15 October 2019 — From: Documents Ref: PHE Publications Gateway Number 2019074 15 October 2019 Added pre-school guidance for the 2019 to 2020 flu season. 18 September 2018 Added revised guidance for early years childcare settings. 7 September (...) Flu immunisation for early years settings including child minders Flu immunisation for early years settings including child minders - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Register by 26 November to vote

2020 Public Health England

14. Flu in the children and young people’s secure estate

Flu in the children and young people’s secure estate Seasonal flu in the children and young people’s secure estate - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Register by 26 November to vote in the General Election (...) on 12 December. Guidance Seasonal flu in the children and young people’s secure estate Guidance for healthcare and residential staff to help them respond to individual flu cases and manage outbreaks. Published 23 November 2017 Last updated 14 October 2019 — From: Documents Ref: PHE publications gateway number: GW-803 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need

2020 Public Health England

15. Flu in prisons and secure settings: information for staff

Flu in prisons and secure settings: information for staff Flu: information for prison and detention centre staff in England - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Register by 26 November to vote in the General (...) Election on 12 December. Guidance Flu: information for prison and detention centre staff in England How to respond to individual cases or outbreaks of seasonal flu, including vaccination, recommendations and managing outbreaks. Published 1 October 2013 Last updated 14 October 2019 — From: Documents Ref: PHE publications gateway number GW-802 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what

2020 Public Health England

16. Flu vaccination in schools

Flu vaccination in schools Flu vaccination in schools - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance Flu vaccination in schools Flu vaccination guidance and resources for schools. Published 11 May 2017 Last updated 24 July 2020 — From: Documents Ref: PHE (...) 2020114 MS Word Document , 142KB This file may not be suitable for users of assistive technology. If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details Resources to support flu vaccination in schools. Advice for school teams This guidance has been produced to assist all school staff and headteachers with any

2020 Public Health England

17. Systematic review of the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines

Systematic review of the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines Systematic review of the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines | HIQA Header Tasks Menu COVID-19 HIQA’s is supporting the National Public Health Emergency Team in its response to COVID-19. Systematic review of the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines Search Search Systematic review (...) of the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines Main navigation - HTA Contact Us 021 240 9300 Follow Us Receive SMS News Alerts Text HIQA to 51155 to subscribe to our free SMS alerts. Text HIQASTOP to 51155 to unsubscribe. for More info. Receive Our Newsletter Footer Links Health Information and Quality Authority ©

2020 Health Information and Quality Authority

18. Flu vaccination: who should have it this winter and why

should have it this winter and why Leaflet explaining the importance of the influenza (flu) vaccination this winter 2020 to 2021. Published 6 August 2015 Last updated 28 September 2020 — From: Documents HTML Ref: PHE publications gateway number 2020106 . Please tell us what format you need. It will help us if you say what assistive technology you use. Ref: Public Health England gateway number 2020224 . Please tell us what format you need. It will help us if you say what assistive technology you use (...) Flu vaccination: who should have it this winter and why Flu vaccination: who should have it this winter and why - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Show or hide search Search on GOV.UK Menu Guidance and support Take action now for new rules in 2021 Guidance Flu vaccination: who

2020 Public Health England

19. Health matters: flu immunisation programme and COVID-19

Health matters: flu immunisation programme and COVID-19 Health matters: flu immunisation programme and COVID-19 - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Show or hide search Search on GOV.UK Menu Guidance and support Take action now for new rules in 2021 Guidance Health matters: flu (...) immunisation programme and COVID-19 This edition focuses on the national flu immunisation programme during the first winter of co-circulation of flu and COVID-19. Published 29 September 2020 From: Documents HTML Details The 2020 to 2021 national flu immunisation programme will be the largest one to date, offering 30 million people a flu vaccine. This resource focuses on the delivery of the programme, co-infection of flu and COVID-19 and calls to action for the wider health economy and local authorities

2020 Public Health England

20. Vaccine recommendations for children and youth for the 2020/2021 influenza season

Vaccine recommendations for children and youth for the 2020/2021 influenza season The Canadian Paediatric Society continues to encourage annual influenza vaccination for ALL children and youth 6 months of age and older. Recommendations from the National Advisory Committee on Immunization (NACI) for the 2020/2021 influenza season are not substantially changed from those of last season except for permitting the use of live attenuated influenza vaccine in selected children with well-controlled HIV (...) infection. Quadrivalent vaccine, if available, is recommended for children 6 months to 17 years of age. Either inactivated influenza vaccine or live attenuated influenza vaccine may be used for children and youth 2 to 17 years of age who are not immunocompromised. LAIV will again be available in Canada for the 2020/2021 season. NACI has also addressed issues related to provision of influenza vaccine during the COVID-19 pandemic. Keywords:   Children; COVID-19; Influenza vaccine; Inactivated

2020 Canadian Paediatric Society